Roche Nimblegen - Madison, Wisconsin Area Mar 2007 - Jul 2012
Sr. Desktop Support Specialist
Kelly Services Sep 2006 - Feb 2007
PC Technician
High Desert Computing Technologies Dec 2002 - Jul 2006
Owner / Senior Technician
Education:
New Horizons Computer Learning Center Madison, WI. 2011 - 2011
New Horizons Computer Learning Center Bakersfield, Ca. 2000 - 2000
University of Alaska Fairbanks 1993 - 1993
Skills:
Rx Windows Server Help Desk Support Windows Server Support Hp Service Manager Citrix Active Directory Computer Hardware Service Desk Itil Backup Exec Windows Software Installation Networking Remote User Support Hp Service Desk System Administration Microsoft Dynamics Cvs Norton Ghost Microsoft Office Altiris Disaster Recovery Windows Xp Windows 7 Microsoft Crm Technical Support System Imaging Red Hat Linux Support Blackberry Enterprise Server Client Administration Vmware Infrastructure Laptops Windows Xp Pro Desktop Computers System Deployment Vmware Hardware Software Licensing It Service Management Group Policy
Interests:
Football Casinos Exercise Sweepstakes Nascar Home Improvement Reading Sports Watching Basketball Golf Fishing Home Decoration Watching Sports Cooking Cruises Outdoors Electronics Fitness Music Camping Movies Collecting Diet Cats Woodwork Travel Boating Investing Traveling Basketball Sports Memorabilia Collecting Watching Football
Dr. Downing graduated from the Indiana University School of Medicine in 1989. He works in Kokomo, IN and specializes in Pulmonary Disease. Dr. Downing is affiliated with Community Howard Regional Health and Saint Vincent Kokomo.
in all, spent a little time at an airport gate before takeoff. The children were able to interact with more than a dozen therapy dogs brought in just for the event. Then, around 7 p.m., those gathered -- which included St. Jude President Dr. James Downing -- boarded the 757 airplane for the "flight."
Date: Dec 21, 2016
Category: Business
Source: Google
Certain Genes Do Increase Risk of Chilhood Cancers
The study led by the CEO and president of the hospital Dr. James Downing is part of the Pediatric Genome Project, which both teams have been working on. Considered as the "most ambitious effort," it seeks to determine the beginnings of childhood cancers to be able to find the precise medicine. It lo
These findings "give us fundamental insights into the etiology of pediatric cancerto help treat patients," says James Downing, chair of Childhood Cancer Treatment, president and CEO of St. Jude Children's Research Hospital and co-author of the new study, which is part of the Saint JudeWashington U
Date: Nov 18, 2015
Category: Health
Source: Google
More Than 8 Percent of Kids With Cancer May Be Genetically Prone to the Disease
"This paper marks an important turning point in our understanding of pediatric cancer risk and will likely change how patients are evaluated," corresponding author Dr. James Downing, St. Jude president and chief executive officer, said in a news release from the Memphis hospital.
Also speaking at the ceremony was Lt. Col. Steven Clark, commander of WVU Army ROTC, who brought the audiences attention to retired Navy Lt. James Downing, who was present at the attacks on Pearl Harbor.
Date: Dec 07, 2014
Category: U.S.
Source: Google
Hillary Clinton Visits St. Jude Hospital, Helps Open $200 Million Center
The Marlo Thomas Center for Global Education and Collaboration will also host a college graduate and post-doctoral fellow program; St. Jude will become a degree-granting institution, added St. Jude CEO Dr. James Downing.
Date: Nov 24, 2014
Category: Health
Source: Google
DNA sequencing project could lead to treatments for deadly childhood cancers
Early on, target gene sequencing only looked at the part of the genome of interestWe knew in pediatric tumors, there are a large number of structural alterations, and [less comprehensive] approaches could not detect those abnormalities, Dr. James Downing, the St. Jude scientific director who lea
Date: May 30, 2012
Category: Health
Source: Google
Decoding Cancer: Scientists Release 520 Tumor Genomes from Pediatric Patients
f we only sequenced the tumor, and not normal non-tumor DNA from the patient, we would end up with thousands to hundreds of thousands of potential mutations, and no way to sort through which ones were important to cancer, says Dr. James Downing, scientific director and leader of the PCGP at St. Jud